Quidel Corp
NASDAQ:QDEL

Watchlist Manager
Quidel Corp Logo
Quidel Corp
NASDAQ:QDEL
Watchlist
Price: 46.03 USD -1.88% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
Quidel Corp?
Write Note

Quidel Corp
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Quidel Corp
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Quidel Corp
NASDAQ:QDEL
Total Assets
$6.8B
CAGR 3-Years
48%
CAGR 5-Years
51%
CAGR 10-Years
38%
Haemonetics Corp
NYSE:HAE
Total Assets
$2.5B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Total Assets
$4.3B
CAGR 3-Years
33%
CAGR 5-Years
21%
CAGR 10-Years
23%
Align Technology Inc
NASDAQ:ALGN
Total Assets
$6.4B
CAGR 3-Years
4%
CAGR 5-Years
22%
CAGR 10-Years
21%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Assets
$2B
CAGR 3-Years
34%
CAGR 5-Years
38%
CAGR 10-Years
23%
Merit Medical Systems Inc
NASDAQ:MMSI
Total Assets
$2.4B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
12%
No Stocks Found

Quidel Corp
Glance View

Market Cap
3.1B USD
Industry
Health Care

Quidel Corporation, a player in the diagnostic healthcare industry, has steadily navigated the labyrinth of medical innovation, carving out a niche in rapid diagnostic testing. Born out of a mission to streamline the process of disease detection, Quidel has leveraged biotechnology to develop fast, reliable diagnostic solutions that address widespread health issues. This company’s arsenal includes tests for infectious diseases, reproductive health, and autoimmune disorders—each meticulously designed to expedite the diagnostic process while maintaining a stringent commitment to accuracy. By fostering partnerships with healthcare providers and aligning with technological advancements, Quidel has positioned itself as indispensable in the clinic setting, where swift decision-making can significantly impact patient care. At the heart of Quidel's business model is its focus on providing tangible value to both healthcare professionals and patients. The company generates revenue primarily through the sale of its diagnostic products, which are utilized in settings ranging from small clinics to large hospital networks. Quidel's innovative platforms, like the Sofia and Solana systems, are lauded for their efficiency and ease of use, attributes that resonate particularly well in medical environments under pressure to deliver fast and effective results. By effectively converting scientific expertise into practical and user-friendly applications, Quidel not only enhances patient outcomes but also fortifies its financial standing within the competitive landscape of medical diagnostics.

QDEL Intrinsic Value
65.88 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Quidel Corp's Total Assets?
Total Assets
6.8B USD

Based on the financial report for Sep 29, 2024, Quidel Corp's Total Assets amounts to 6.8B USD.

What is Quidel Corp's Total Assets growth rate?
Total Assets CAGR 10Y
38%

Over the last year, the Total Assets growth was -20%. The average annual Total Assets growth rates for Quidel Corp have been 48% over the past three years , 51% over the past five years , and 38% over the past ten years .

Back to Top